PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
308.03%
Net income growth above 1.5x MRVL's 21.67%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
-1.58%
Negative yoy D&A while MRVL is 1.08%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-13.89%
Negative yoy deferred tax while MRVL stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
-100.00%
Negative yoy SBC while MRVL is 0.00%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
-34.38%
Negative yoy working capital usage while MRVL is 101.39%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
100.00%
AR growth of 100.00% while MRVL is zero at 0.00%. Bruce Berkowitz would see a mild difference in credit approach that could matter for cash flow.
-56.14%
Both reduce yoy inventory, with MRVL at -106.14%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
100.00%
AP growth of 100.00% while MRVL is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might matter for short-term liquidity if expansions are large.
-804.76%
Negative yoy usage while MRVL is 103.07%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-2998.00%
Negative yoy while MRVL is 0.00%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
14.72%
Operating cash flow growth below 50% of MRVL's 62.73%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
8.33%
Some CapEx rise while MRVL is negative at -5.71%. John Neff would see competitor possibly building capacity while we hold back expansions.
84.18%
Acquisition growth of 84.18% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
-165.98%
Both yoy lines negative, with MRVL at -55.53%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
-15.46%
Both yoy lines are negative, with MRVL at -100.00%. Martin Whitman suspects an environment prompting fewer sales or fewer maturities within the niche.
49700.00%
Growth of 49700.00% while MRVL is zero at 0.00%. Bruce Berkowitz sees a moderate difference requiring justification by ROI in these smaller invests.
146.91%
We have mild expansions while MRVL is negative at -2.33%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
11.58%
Debt repayment growth of 11.58% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
-3.52%
Negative yoy issuance while MRVL is 56.50%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
27.99%
Buyback growth of 27.99% while MRVL is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.